The Medicinal Inorganic Chemistry Group explores the role of metals in health and medicine, with research spanning metal-based drugs, iron supplementation and other pharmaceutical applications of coordination compounds. Over the past decade, our work has increasingly focused on radiopharmaceuticals for diagnosis and therapy, particularly the development of tailored chelators for medically relevant radiometals. We combine ligand design and synthesis with detailed investigations of metal complex formation, stability and behaviour in biologically relevant environments.
Our goal is to understand how molecular structure and coordination chemistry influence biological performance, using this knowledge to guide the development of new diagnostic and therapeutic agents.
UNDER CONSTRUCTION…coming soon…